Ki-67: more than a proliferation marker

X Sun, PD Kaufman - Chromosoma, 2018 - Springer
Ki-67 protein has been widely used as a proliferation marker for human tumor cells for
decades. In recent studies, multiple molecular functions of this large protein have become …

Mutational drivers of cancer cell migration and invasion

NM Novikov, SY Zolotaryova, AM Gautreau… - British journal of …, 2021 - nature.com
Genomic instability and mutations underlie the hallmarks of cancer—genetic alterations
determine cancer cell fate by affecting cell proliferation, apoptosis and immune response …

[HTML][HTML] Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer

KJ Chavez, SV Garimella, S Lipkowitz - Breast disease, 2010 - ncbi.nlm.nih.gov
Breast cancer is the most frequently diagnosed cancer in women and one of the leading
causes of cancer death for women. Worldwide, over 1.3 million cases of invasive breast …

p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

CJ Chang, CH Chao, W Xia, JY Yang, Y Xiong… - Nature cell …, 2011 - nature.com
The epithelial–mesenchymal transition (EMT) has recently been linked to stem cell
phenotype,. However, the molecular mechanism underlying EMT and regulation of …

p53 and its mutants in tumor cell migration and invasion

PAJ Muller, KH Vousden, JC Norman - Journal of Cell Biology, 2011 - rupress.org
In about half of all human cancers, the tumor suppressor p53 protein is either lost or
mutated, frequently resulting in the expression of a transcriptionally inactive mutant p53 …

The tumor suppressor p53: from structures to drug discovery

AC Joerger, AR Fersht - Cold Spring Harbor …, 2010 - cshperspectives.cshlp.org
Even 30 years after its discovery, the tumor suppressor protein p53 is still somewhat of an
enigma. p53's intimate and multifaceted role in the cell cycle is mirrored in its equally …

The rebel angel: mutant p53 as the driving oncogene in breast cancer

D Walerych, M Napoli, L Collavin, G Del Sal - Carcinogenesis, 2012 - academic.oup.com
Breast cancer is the most frequent invasive tumor diagnosed in women, causing over 400
000 deaths yearly worldwide. Like other tumors, it is a disease with a complex …

[HTML][HTML] p53 and metabolism: from mechanism to therapeutics

FM Simabuco, MG Morale, ICB Pavan, AP Morelli… - Oncotarget, 2018 - ncbi.nlm.nih.gov
The tumor cell changes itself and its microenvironment to adapt to different situations,
including action of drugs and other agents targeting tumor control. Therefore, metabolism …

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube–derived high-grade serous ovarian cancers

AM Karst, PM Jones, N Vena, AH Ligon, JF Liu… - Cancer research, 2014 - AACR
The fallopian tube is now generally considered the dominant site of origin for high-grade
serous ovarian carcinoma. However, the molecular pathogenesis of fallopian tube-derived …

Diversity of the senescence phenotype of cancer cells treated with chemotherapeutic agents

A Bojko, J Czarnecka-Herok, A Charzynska… - Cells, 2019 - mdpi.com
It is acknowledged that cancer cells are able to undergo senescence in response to
clinically used chemotherapeutics. Moreover, recent years have provided evidence that …